Regulation of mast cell development by c-kit receptor and its ligand

The c-kit receptor tyrosine kinase and its ligand, stem cell factor (SCF), play an important role for regulation of mast cells. The symptoms of mouse mutants at either c-kit or SCF gene apparently show the physiological significance of the signal through the c-kit receptor tyrosine kinase. The number of mast cells in the skin of various murine c-kit mutants may be explained by the type and severity of the mutations. All mutations reported in mice and rats are loss-of-function mutations, but we recently found a gain-of-function mutation of c-kit in mastocytoma cell lines. In these mastocytoma cell lines, the c-kit receptor tyrosine kinase is activated constitutively without binding of SCF. The c-kit receptor tyrosine kinase appears to be important not only for development of mast cells but also for neoplastic transformation of mast cells.

[1]  K. Tohya,et al.  Characterization of cultured mast cells derived from Ws/Ws mast cell-deficient rats with a small deletion at tyrosine kinase domain of c-kit. , 1994, Blood.

[2]  Y. Kitamura,et al.  Wn mutation of c-kit receptor affects its post-translational processing and extracellular expression. , 1994, Oncogene.

[3]  Y. Matsuzawa,et al.  Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation. , 1994, Blood.

[4]  L. Ashman,et al.  Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. , 1993, The Journal of clinical investigation.

[5]  Y. Kitamura,et al.  Development of mast cells and basophils: processes and regulation mechanisms. , 1993, The American journal of the medical sciences.

[6]  A. Zelenetz,et al.  W-sash affects positive and negative elements controlling c-kit expression: ectopic c-kit expression at sites of kit-ligand expression affects melanogenesis. , 1993, Development.

[7]  Y. Nishimune,et al.  Mast cell number in the skin of heterozygotes reflects the molecular nature of c-kit mutation. , 1993, Blood.

[8]  S. Galli,et al.  Reversible expansion of primate mast cell populations in vivo by stem cell factor. , 1993, The Journal of clinical investigation.

[9]  S. Lev,et al.  Dimerization and activation of the kit receptor by monovalent and bivalent binding of the stem cell factor. , 1992, The Journal of biological chemistry.

[10]  S. Lev,et al.  A recombinant ectodomain of the receptor for the stem cell factor (SCF) retains ligand-induced receptor dimerization and antagonizes SCF-stimulated cellular responses. , 1992, Journal of Biological Chemistry.

[11]  S. Nishikawa,et al.  Necessity of extracellular domain of W (c-kit) receptors for attachment of murine cultured mast cells to fibroblasts. , 1992, Blood.

[12]  S. Lev,et al.  Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  E. Morii,et al.  Characterization of Ws mutant allele of rats: a 12-base deletion in tyrosine kinase domain of c-kit gene. , 1991, Blood.

[14]  Y. Kitamura,et al.  Anemia and mast cell depletion in mutant rats that are homozygous at "white spotting (Ws)" locus. , 1991, Blood.

[15]  Y. Kitamura,et al.  Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells , 1991, The Journal of experimental medicine.

[16]  M. Tsai,et al.  The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype , 1991, The Journal of experimental medicine.

[17]  S. Naylor,et al.  Mouse platelet-derived growth factor receptor alpha gene is deleted in W19H and patch mutations on chromosome 5. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Nishikawa,et al.  Exon skipping by mutation of an authentic splice site of c-kit gene in W/W mouse. , 1991, Nucleic acids research.

[19]  P. Leder,et al.  Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the SId mutant , 1991, Cell.

[20]  T. Mosmann,et al.  Interleukin 10: a novel stimulatory factor for mast cells and their progenitors , 1991, The Journal of experimental medicine.

[21]  D A Stephenson,et al.  Platelet-derived growth factor receptor alpha-subunit gene (Pdgfra) is deleted in the mouse patch (Ph) mutation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[22]  P. Leder,et al.  The hematopoietic growth factor KL is encoded by the SI locus and is the ligand of the c-kit receptor, the gene product of the W locus , 1990, Cell.

[23]  C. March,et al.  Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms , 1990, Cell.

[24]  K. Zsebo,et al.  Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver-conditioned medium , 1990, Cell.

[25]  P. Leder,et al.  The kit ligand: A cell surface molecule altered in steel mutant fibroblasts , 1990, Cell.

[26]  C. March,et al.  Identification of a ligand for the c-kit proto-oncogene , 1990, Cell.

[27]  K. Nocka,et al.  Molecular bases of dominant negative and loss of function mutations at the murine c‐kit/white spotting locus: W37, Wv, W41 and W. , 1990, The EMBO journal.

[28]  A. Reith,et al.  W mutant mice with mild or severe developmental defects contain distinct point mutations in the kinase domain of the c-kit receptor. , 1990, Genes & development.

[29]  K. Nocka,et al.  The dominant W42 spotting phenotype results from a missense mutation in the c-kit receptor kinase. , 1990, Science.

[30]  J. Ring,et al.  Thiol-sensitive mast cell lines derived from mouse bone marrow respond to a mast cell growth-enhancing activity different from both IL-3 and IL-4. , 1989, Journal of immunology.

[31]  Y. Kanakura,et al.  In vitro duplication and in vivo cure of mast-cell deficiency of Sl/Sld mutant mice by cloned 3T3 fibroblasts. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Y. Kitamura,et al.  Heterogeneity of mast cells and phenotypic change between subpopulations. , 1989, Annual review of immunology.

[33]  D. Housman,et al.  The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene , 1988, Cell.

[34]  V. Chapman,et al.  The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus , 1988, Nature.

[35]  N. Arizono,et al.  Kinetics and staining properties of mast cells proliferating in rat small intestine tunica muscularis and subserosa following infection with Nippostrongylus brasiliensis , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[36]  F. Ruddle,et al.  Primary structure of c‐kit: relationship with the CSF‐1/PDGF receptor kinase family–oncogenic activation of v‐kit involves deletion of extracellular domain and C terminus. , 1988, The EMBO journal.

[37]  T. Honjo,et al.  Fibroblast‐dependent growth of mouse mast cells in vitro: Duplication of mast cell depletion in mutant mice of w/wv genotype , 1988, Journal of cellular physiology.

[38]  Y. Kitamura,et al.  Failure of W/Wv mouse-derived cultured mast cells to enter S phase upon contact with NIH/3T3 fibroblasts. , 1988, Blood.

[39]  A. Ullrich,et al.  Human proto‐oncogene c‐kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. , 1987, The EMBO journal.

[40]  John E. Murphy,et al.  A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family , 1986, Nature.

[41]  R. Coffman,et al.  Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[42]  M. Lyon,et al.  A presumed deletion covering the W and Ph loci of the mouse. , 1984, Genetical research.

[43]  T. Taguchi,et al.  Effect of the Slt mutant allele on the production of tissue mast cells in mice. , 1983, Journal of Heredity.

[44]  J. Ihle,et al.  Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity. , 1983, Journal of immunology.

[45]  Y. Kitamura,et al.  Effect of W and Wυ alleles on production of tissue mast cells in mice , 1980 .

[46]  J. Bienenstock,et al.  Immunologically mediated intestinal mastocytosis in Nippostrongylus brasiliensis-infected rats. , 1979, Immunology.

[47]  G. Mayrhofer,et al.  Mast cells in severely T-cell depleted rats and the response to infestation with Nippostrongylus brasiliensis. , 1979, Immunology.

[48]  Y. Kitamura,et al.  Decreased production of mast cells in S1/S1d anemic mice. , 1979, Blood.

[49]  Y. Kitamura,et al.  Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. , 1978, Blood.

[50]  R. Levi‐montalcini,et al.  Mast cells increase in tissues of neonatal rats injected with the nerve growth factor , 1977, Brain Research.

[51]  E. Ruitenberg,et al.  Absence of intestinal mast cell response in congenitally athymic mice during Trichinella spiralis infection , 1976, Nature.